Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114573512B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN114573512B enables mild visible light synthesis. Reduces toxicity and cost for pharmaceutical intermediates manufacturing supply chain.